ISOTOPE TECHNOLOGIES (EGFF)
Financed · Germany
Source: European Investment Bank (EIB)
The project concerns RDI investments of a proprietary portfolio of nuclear medicine solutions for diagnosis and treatment of cancer, addressing a range of indications such as neuroendocrine tumours, bone metastases or prostate cancers. This portfolio includes new radionuclides and radiopharmaceuticals in various stages of clinical development, covering discovery, pre-clinical and clinical (Phase
- Status
- Prospective
- Sector
- Nuclear, Hospital, Hotel, Manufacturing (Industrial), Government
- Location
- Germany
- Updated
- 19 Nov 2026
- Source
- European Investment Bank (EIB)
ConstructChat
Ask ConstructChat about ISOTOPE TECHNOLOGIES (EGFF)
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | financed |
Taiyo status | Prospective |
Taiyo last update | 2026-11-19 |
Contact
| Not available for this record. |
Description
Description | The project concerns RDI investments of a proprietary portfolio of nuclear medicine solutions for diagnosis and treatment of cancer, addressing a range of indications such as neuroendocrine tumours, bone metastases or prostate cancers. This portfolio includes new radionuclides and radiopharmaceuticals in various stages of clinical development, covering discovery, pre-clinical and clinical (Phase I-III) and technical validation phases. |
Original sector | Services |
Budget |
Location
Country | Germany |
Source
Source reliability | High |
Source | European Investment Bank (EIB) |
URL |
More Details
Record type | Project |
Sector | Nuclear, Hospital, Hotel, Manufacturing (Industrial), Government |
Article published date | 2023-05-08 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
